227 related articles for article (PubMed ID: 1929246)
1. Antimicrobial susceptibility and molecular epidemiology of beta-lactamase-producing, aminoglycoside-resistant isolates of Enterococcus faecalis.
Markowitz SM; Wells VD; Williams DS; Stuart CG; Coudron PE; Wong ES
Antimicrob Agents Chemother; 1991 Jun; 35(6):1075-80. PubMed ID: 1929246
[TBL] [Abstract][Full Text] [Related]
2. Comparison of ampicillin-sulbactam with vancomycin for treatment of experimental endocarditis due to a beta-lactamase-producing, highly gentamicin-resistant isolate of Enterococcus faecalis.
Lavoie SR; Wong ES; Coudron PE; Williams DS; Markowitz SM
Antimicrob Agents Chemother; 1993 Jul; 37(7):1447-51. PubMed ID: 8363374
[TBL] [Abstract][Full Text] [Related]
3. Time-kill and synergism studies of ceftobiprole against Enterococcus faecalis, including beta-lactamase-producing and vancomycin-resistant isolates.
Arias CA; Singh KV; Panesso D; Murray BE
Antimicrob Agents Chemother; 2007 Jun; 51(6):2043-7. PubMed ID: 17438057
[TBL] [Abstract][Full Text] [Related]
4. Chemoprophylactic efficacy against experimental endocarditis caused by beta-lactamase-producing, aminoglycoside-resistant enterococci is associated with prolonged serum inhibitory activity.
Bayer AS; Tu J
Antimicrob Agents Chemother; 1990 Jun; 34(6):1068-74. PubMed ID: 2118323
[TBL] [Abstract][Full Text] [Related]
5. Activities and time-kill studies of selected penicillins, beta-lactamase inhibitor combinations, and glycopeptides against Enterococcus faecalis.
Hoellman DB; Visalli MA; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1998 Apr; 42(4):857-61. PubMed ID: 9559796
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility of Enterococcus faecalis to twelve antibiotics, time-kill assays, and high-level aminoglycoside resistance in a university hospital in Argentina.
Predari SC; Gutiérrez MA; Ribas C; Molinari GS; Santoianni JE
Rev Argent Microbiol; 1991; 23(2):67-78. PubMed ID: 1815269
[TBL] [Abstract][Full Text] [Related]
7. Susceptibility and bactericidal activity studies of four beta-lactamase-producing enterococci.
Patterson JE; Zervos MJ
Antimicrob Agents Chemother; 1989 Feb; 33(2):251-3. PubMed ID: 2497706
[TBL] [Abstract][Full Text] [Related]
8. Treatment of experimental endocarditis caused by a beta-lactamase-producing strain of Enterococcus faecalis with high-level resistance to gentamicin.
Hindes RG; Willey SH; Eliopoulos GM; Rice LB; Eliopoulos CT; Murray BE; Moellering RC
Antimicrob Agents Chemother; 1989 Jul; 33(7):1019-22. PubMed ID: 2506803
[TBL] [Abstract][Full Text] [Related]
9. Comparison of in vitro inhibitory and bactericidal activities of daptomycin (LY 146032) and four reference antibiotics, singly and in combination, against gentamicin-susceptible and high-level-gentamicin-resistant enterococci.
Louie A; Baltch AL; Ritz WJ; Smith RP; Asperilla M
Chemotherapy; 1993; 39(5):302-9. PubMed ID: 8396526
[TBL] [Abstract][Full Text] [Related]
10. Comparison of daptomycin, vancomycin, and ampicillin-gentamicin for treatment of experimental endocarditis caused by penicillin-resistant enterococci.
Ramos MC; Grayson ML; Eliopoulos GM; Bayer AS
Antimicrob Agents Chemother; 1992 Sep; 36(9):1864-9. PubMed ID: 1329632
[TBL] [Abstract][Full Text] [Related]
11. Early in vitro development of daptomycin non-susceptibility in high-level aminoglycoside-resistant Enterococcus faecalis predicts the efficacy of the combination of high-dose daptomycin plus ampicillin in an in vivo model of experimental endocarditis.
Pericàs JM; García-de-la-Mària C; Brunet M; Armero Y; García-González J; Casals G; Almela M; Quintana E; Falces C; Ninot S; Fuster D; Llopis J; Marco F; Moreno A; Miró JM;
J Antimicrob Chemother; 2017 Jun; 72(6):1714-1722. PubMed ID: 28204495
[TBL] [Abstract][Full Text] [Related]
12. Chromosomally mediated beta-lactamase production and gentamicin resistance in Enterococcus faecalis.
Rice LB; Eliopoulos GM; Wennersten C; Goldmann D; Jacoby GA; Moellering RC
Antimicrob Agents Chemother; 1991 Feb; 35(2):272-6. PubMed ID: 1902647
[TBL] [Abstract][Full Text] [Related]
13. Diversity among high-level aminoglycoside-resistant enterococci.
Papaparaskevas J; Vatopoulos A; Tassios PT; Avlami A; Legakis NJ; Kalapothaki V
J Antimicrob Chemother; 2000 Mar; 45(3):277-83. PubMed ID: 10702545
[TBL] [Abstract][Full Text] [Related]
14. Time-kill kinetic studies of ampicillin/sulbactam for beta-lactamase-producing enterococci.
Patterson JE; Farrel P; Zervos MJ
Diagn Microbiol Infect Dis; 1991; 14(6):495-9. PubMed ID: 1802536
[TBL] [Abstract][Full Text] [Related]
15. In vitro activities of quinolones against enterococci resistant to penicillin-aminoglycoside synergy.
Sahm DF; Koburov GT
Antimicrob Agents Chemother; 1989 Jan; 33(1):71-7. PubMed ID: 2496659
[TBL] [Abstract][Full Text] [Related]
16. Comparison of two beta-lactamase-producing strains of Streptococcus faecalis.
Murray BE; Church DA; Wanger A; Zscheck K; Levison ME; Ingerman MJ; Abrutyn E; Mederski-Samoraj B
Antimicrob Agents Chemother; 1986 Dec; 30(6):861-4. PubMed ID: 3028251
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Enterococcus faecalis clinical isolates with 'penicillin-resistant, ampicillin-susceptible' phenotype as reported by Vitek-2 Compact system.
Tan YE; Ng LS; Tan TY
Pathology; 2014 Oct; 46(6):544-50. PubMed ID: 25158809
[TBL] [Abstract][Full Text] [Related]
18. Impact of Enterococcus faecalis on the bactericidal activities of arbekacin, daptomycin, linezolid, and tigecycline against methicillin-resistant Staphylococcus aureus in a mixed-pathogen pharmacodynamic model.
LaPlante KL; Rybak MJ; Leuthner KD; Chin JN
Antimicrob Agents Chemother; 2006 Apr; 50(4):1298-303. PubMed ID: 16569844
[TBL] [Abstract][Full Text] [Related]
19. Bactericidal activities of peptide antibiotics against multidrug-resistant Enterococcus faecium.
Mobarakai N; Quale JM; Landman D
Antimicrob Agents Chemother; 1994 Feb; 38(2):385-7. PubMed ID: 8192473
[TBL] [Abstract][Full Text] [Related]
20. Genotypic characterization of a nosocomial outbreak of VanA Enterococcus faecalis.
Biavasco F; Miele A; Vignaroli C; Manso E; Lupidi R; Varaldo PE
Microb Drug Resist; 1996; 2(2):231-7. PubMed ID: 9158765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
